Información: Esta es una versión obsoleta del modelo de datos. En la sección izquierda, bajo "Versiones", se encuentra el historial de versiones. Puede acceder a la versión actual a través del siguiente link: here.
Información:
Error:
ID
31817
Descripción
Study ID: 104574 Clinical Study ID: AR1104574 Study Title: A randomized blinded pilot trial of fondaparinux sodium (Arixtra®) versus unfractionated heparin in addition to standard therapy in a broad range of patients undergoing percutaneous coronary intervention (ASPIRE) Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: Sponsor: GlaxoSmithKline Collaborators: N/A Phase: Phase 2 Study Recruitment Status: Completed Generic Name: fondaparinux sodium Trade Name: Arixtra Study Indication: Thromboembolism
Palabras clave
Versiones (2)
- 1/10/18 1/10/18 -
- 20/9/21 20/9/21 -
Titular de derechos de autor
GlaxoSmithKline
Subido en
1 de octubre de 2018
DOI
Para solicitar uno, por favor iniciar sesión.
Licencia
Creative Commons BY-NC 3.0
Comentarios del modelo :
Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.
Comentarios de grupo de elementos para :
Comentarios del elemento para :
Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.
Fondaparinux sodium (Arixtra) versus unfractionated heparin with patients undergoing PCI; NCT
Hospital Discharge Visit
- StudyEvent: ODM
Similar models
Hospital Discharge Visit
- StudyEvent: ODM
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
Patient ID; Centre Number
Item
Patient ID, Centre No.
text
C1269815 (UMLS CUI [1,1])
C2825181 (UMLS CUI [1,2])
C1300638 (UMLS CUI [1,3])
C2825181 (UMLS CUI [1,2])
C1300638 (UMLS CUI [1,3])
Patient ID; Envelope Number
Item
Patient ID, Envelope No.
text
C1269815 (UMLS CUI [1,1])
C2348585 (UMLS CUI [1,2])
C2348585 (UMLS CUI [1,2])
Patient Initials
Item
Patient Initials
text
C2986440 (UMLS CUI [1])
Item
How were these follow-up data obtained?
text
C1522577 (UMLS CUI [1,1])
C0681794 (UMLS CUI [1,2])
C0681794 (UMLS CUI [1,2])
CL Item
office visit (office visit)
CL Item
home visit (home visit)
CL Item
telephone communication (telephone communication)
CL Item
Patient in hospital, not discharged after initial PCI (Patient in hospital, not discharged after initial PCI)
CL Item
Patient in hospital, readmitted to hospital after initial PCI (Patient in hospital, readmitted to hospital after initial PCI)
CL Item
written communication (written communication)
CL Item
other (specify) (other (specify))
Adverse Event; Cessation of life
Item
Death
boolean
C0877248 (UMLS CUI [1,1])
C0011065 (UMLS CUI [1,2])
C0011065 (UMLS CUI [1,2])
Adverse Event, Myocardial infarction; Adverse Event, Myocardial Reinfarction
Item
Myocardial (re)Infarction
boolean
C0877248 (UMLS CUI [1,1])
C0027051 (UMLS CUI [1,2])
C0877248 (UMLS CUI [2,1])
C0948369 (UMLS CUI [2,2])
C0027051 (UMLS CUI [1,2])
C0877248 (UMLS CUI [2,1])
C0948369 (UMLS CUI [2,2])
Adverse Event, Revascularization
Item
Revascularization
boolean
C0877248 (UMLS CUI [1,1])
C0581603 (UMLS CUI [1,2])
C0581603 (UMLS CUI [1,2])
Adverse Event, Major bleed; Adverse event, Minor bleed
Item
Clinically overt major and/or minor bleed
boolean
C0877248 (UMLS CUI [1,1])
C3160769 (UMLS CUI [1,2])
C0877248 (UMLS CUI [2,1])
C3160770 (UMLS CUI [2,2])
C3160769 (UMLS CUI [1,2])
C0877248 (UMLS CUI [2,1])
C3160770 (UMLS CUI [2,2])
Adverse Event, Cardiac Arrest; Adverse Event, Cardiac Arrhythmia, Life Threatening
Item
Non-fatal cardiac arrest/life threatening arrhythmia
boolean
C0877248 (UMLS CUI [1,1])
C0018790 (UMLS CUI [1,2])
C0877248 (UMLS CUI [2,1])
C0003811 (UMLS CUI [2,2])
C2826244 (UMLS CUI [2,3])
C0018790 (UMLS CUI [1,2])
C0877248 (UMLS CUI [2,1])
C0003811 (UMLS CUI [2,2])
C2826244 (UMLS CUI [2,3])
Adverse Event, Cerebrovascular accident
Item
Stroke
boolean
C0877248 (UMLS CUI [1,1])
C0038454 (UMLS CUI [1,2])
C0038454 (UMLS CUI [1,2])
Adverse Event, vascular access, Site of access, Hematoma
Item
Vascular Access Site Hematoma
boolean
C0877248 (UMLS CUI [1,1])
C0750138 (UMLS CUI [1,2])
C0589360 (UMLS CUI [1,3])
C0018944 (UMLS CUI [1,4])
C0750138 (UMLS CUI [1,2])
C0589360 (UMLS CUI [1,3])
C0018944 (UMLS CUI [1,4])
Adverse Event, Pseudoaneurysm
Item
Pseudoaneurysm requiring closure
boolean
C0877248 (UMLS CUI [1,1])
C1510412 (UMLS CUI [1,2])
C1510412 (UMLS CUI [1,2])
Adverse Event, other
Item
Has patient experienced any other untoward medical occurrence?
boolean
C0877248 (UMLS CUI [1,1])
C0205394 (UMLS CUI [1,2])
C0205394 (UMLS CUI [1,2])
Item Group
Interventions since Index PCI
C0184661 (UMLS CUI-1)
C1711239 (UMLS CUI-2)
C1532338 (UMLS CUI-3)
C1711239 (UMLS CUI-2)
C1532338 (UMLS CUI-3)
Interventional Procedure; Coronary Angiography
Item
Coronary angiography
boolean
C0184661 (UMLS CUI [1,1])
C0085532 (UMLS CUI [1,2])
C0085532 (UMLS CUI [1,2])
Interventional Procedure; Percutaneous Coronary Intervention; Repeat Surgery
Item
Repeat PCI
boolean
C0184661 (UMLS CUI [1,1])
C1532338 (UMLS CUI [1,2])
C0035110 (UMLS CUI [1,3])
C1532338 (UMLS CUI [1,2])
C0035110 (UMLS CUI [1,3])
Interventional Procedure; Coronary Artery Bypass Surgery
Item
CABG
boolean
C0184661 (UMLS CUI [1,1])
C0010055 (UMLS CUI [1,2])
C0010055 (UMLS CUI [1,2])
Interventional Procedure; Thrombolytic Therapy
Item
Thrombolytic Therapy
boolean
C0184661 (UMLS CUI [1,1])
C0040044 (UMLS CUI [1,2])
C0040044 (UMLS CUI [1,2])
Interventional Procedure; Intra-Aortic Balloon Pumping
Item
Intra-aortic balloon pump
boolean
C0184661 (UMLS CUI [1,1])
C0021860 (UMLS CUI [1,2])
C0021860 (UMLS CUI [1,2])
Interventional Procedure; Vascular Surgical Procedures
Item
Other vascular procedure(s):
boolean
C0184661 (UMLS CUI [1,1])
C0042381 (UMLS CUI [1,2])
C0042381 (UMLS CUI [1,2])
CL Item
Give start and end date and time (Give start and end date and time)
CL Item
Give start and end date and time (Give start and end date and time)
CL Item
Give start and end date and time (Give start and end date and time)
CL Item
Give start and end date and time (Give start and end date and time)
Item
Bivalirudin or Hirudin
text
C0168273 (UMLS CUI [1])
C0019573 (UMLS CUI [2])
C0019573 (UMLS CUI [2])
CL Item
Give start and end date and time (Give start and end date and time)
CL Item
Give start and end date and time (Give start and end date and time)
CL Item
Give start and end date and time (Give start and end date and time)
CL Item
Give start and end date and time (Give start and end date and time)
CL Item
Give start and end date and time (Give start and end date and time)
Item
Other NSAIDs
text
C0003211 (UMLS CUI [1,1])
C0205394 (UMLS CUI [1,2])
C0205394 (UMLS CUI [1,2])
CL Item
Give start and end date and time (Give start and end date and time)
CL Item
Give start and end date and time (Give start and end date and time)
CL Item
Give start and end date and time (Give start and end date and time)
CL Item
Give start and end date and time (Give start and end date and time)
CL Item
Give start and end date and time (Give start and end date and time)
CL Item
Give start and end date and time (Give start and end date and time)
CL Item
Give start and end date and time (Give start and end date and time)
CL Item
Give start and end date and time (Give start and end date and time)
CL Item
Give start and end date and time (Give start and end date and time)
CL Item
Give start and end date and time (Give start and end date and time)
CL Item
Give start and end date and time (Give start and end date and time)